Bioventus’ (BVS) Buy Rating Reaffirmed at Canaccord Genuity Group
Bioventus (NYSE:BVS – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at Canaccord Genuity Group in a report released on Monday,Benzinga reports. They presently have a $15.00 price objective on the stock. Canaccord Genuity Group’s price target points to a potential upside of 56.90% from the company’s previous close. Separately, JPMorgan Chase […]
Bioventus (NYSE:BVS – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at Canaccord Genuity Group in a report released on Monday,Benzinga reports. They presently have a $15.00 price objective on the stock. Canaccord Genuity Group’s price target points to a potential upside of 56.90% from the company’s previous close. Separately, JPMorgan Chase […]
